Beyond antibodies in GAD65 autoimmunity: Reframing pathogenesis through intrathecal B–T cell cross-talk
Open Access
- 11 May 2026
- journal article
- editorial
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (20)
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Anti-CD19 CAR T-Cell Therapy in Advanced Stiff-Person Syndrome and Concomitant Myasthenia GravisNeurology Neuroimmunology & Neuroinflammation, 2025
- Chimeric antigen receptor T-cell therapy for stiff-person syndrome: bridging innovation and clinical challenges in neuroimmunologyTherapeutic Advances in Neurological Disorders, 2025
- Stiff-person syndrome and related disorders — diagnosis, mechanisms and therapiesNature Reviews Neurology, 2024
- Successful use of anti-CD19 CAR T cells in severe treatment-refractory stiff-person syndromeProceedings of the National Academy of Sciences, 2024
- Temporal lobe epilepsy with GAD antibodies: neurons killed by T cells not by complement membrane attack complexBrain, 2022
- GAD antibodies in neurological disorders — insights and challengesNature Reviews Neurology, 2020
- Neurologic syndromes related to anti-GAD65Neurology Neuroimmunology & Neuroinflammation, 2020
- Stiff person-syndrome IgG affects presynaptic GABAergic release mechanismsJournal of Neural Transmission, 2014
- Human Stiff person syndrome IgG-containing high-titer anti-GAD65 autoantibodies induce motor dysfunction in ratsExperimental Neurology, 2013
- Presynaptic impairment of cerebellar inhibitory synapses by an autoantibody to glutamate decarboxylaseJournal of the Neurological Sciences, 2000